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Enterovirus 71 (EV71) caused a large outbreak in Taiwan in
1998 with 78 deaths, and smaller outbreaks recurred in 2000
and 2001. The outbreak was recognized because of a large
number of hand, foot, and mouth disease cases and the rapid
deaths of children with the disease. Virologic and pathologic
studies indicated that EV71 was the most important agent relat-
ed to severe and fatal cases and that a neurogenic inflammato-
ry response was involved in the pathogenesis of cardiopul-
monary collapse resulting from fulminant EV71 infection.
Seroepidemiologic study suggested that EV71 had circulated
for at least 16 years and that the accumulation of susceptible
hosts might have triggered the 1998 outbreak. However, a
change in EV71 neurovirulence and host genetic susceptibility
may also have affected the clinical outcome. The Taiwan out-
break shows that worldwide attention should be paid to such
outbreaks, new antiviral drugs should be developed, and that
vaccination of children under 5 years of age may be warranted. 
E
nteroviruses consist of 68 serotypes and usually cause self-
limited infections in children. Enterovirus 71 (EV71) was
first isolated in California in 1969 (1). Since then, EV71 has
been isolated in many parts of the world. Two patterns of EV71
outbreaks have been observed: small outbreaks associated with
occasional patient death and severe outbreaks associated with a
high case-fatality rate. The latter pattern occurred in Bulgaria in
1975 with 44 deaths (2) and Hungary in 1978 with 45 deaths
(3). During the past 5 years severe outbreaks have occurred: in
Malaysia in 1997 with 30 deaths and in Taiwan with 78 deaths
in 1998, 25 deaths in 2000, and 26 deaths in 2001 (4).
How Did the Taiwan Outbreaks Occur?
Sentinel Surveillance Systems in Taiwan
In 1989, a physician-based sentinel surveillance system for
infectious diseases was established in Taiwan and operated by
the Ministry of Health. This system included 850 physicians,
representing 8.7% of primary physicians in Taiwan. Hand, foot,
and mouth disease (HFMD) and herpangina were included in
the system after an outbreak of HFMD in Malaysia in 1997.
When the case incidence after 1997 was compared with the
case incidence of HFMD in 1997, the number of cases in
Taiwan markedly increased after March 1998 (5). Because the
numbers of severe and fatal cases of HFMD were increasing
rapidly, a hospital-based reporting system for monitoring such
cases was added in May 1998. Since June 1998, both physi-
cian-based and hospital-based surveillance systems have been
maintained simultaneously (5).
1998 Outbreak
The 1998 outbreak occurred in two waves. The first and
bigger wave peaked during the week of June 7 and encom-
passed all four regions of Taiwan. The second and smaller wave
occurred during the week of October 4, mainly in southern
Taiwan. The total number of HFMD and herpangina cases
reported was 129,106 (6).
The severe cases of EV71 infection peaked in early June as
well: 405 severe cases were reported with 78 deaths (6). Ninety
one percent of patients with fatal cases were <5 years old (6).
Most of these patients died of fulminant infection within 1 or 2
days of hospitalization. Of 96 patients with severe EV71 cases,
67 (70%) had encephalitis (6). 
Virologic and Pathologic Studies
Of 78 patients with fatal cases, 37 had a positive viral cul-
ture in which 34 (92%) yielded EV71 (4). In 1998, 177 strains
(42%) of EV71, 73 strains (18%) of coxsackievirus A16, and
168 strains (40%) of other enteroviruses (4) were isolated in
Chang Gung Children’s Hospital; only EV71 was isolated from
patients who died or survived with chronic health problems (4).
Thus, EV71 was the most important agent among fatal cases,
although other enteroviruses also circulated during the out-
breaks.
Pathologic studies showed extensive inflammation in the
central nervous system (CNS), with predominant lesions in the
brain stem and spinal cord (7). Marked pulmonary edema with
focal hemorrhage occurred without evidence of myocarditis.
EV71 was isolated from CNS tissues but not from other tissues.
The autopsy findings were similar to those reported in
Malaysia (8).
Clinical, virologic, and pathologic findings suggested that
the CNS, especially the brain stem, is the primary area involved
in severe EV71. We hypothesized that a neurogenic and sys-
temic inflammatory response may be involved in the pathogen-
esis of cardiopulmonary collapse that occurs in severe EV71
infections (Figure). EV71 may invade the CNS through its
presence in the blood or directly through the cranial nerves
(facial or hypopharyngeal nerve) on day 2 to day 5 of illness. A
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a high interleukin 6 level (1326+/-389 pg/mL) in the cere-
brospinal fluid on the first 2 days of CNS involvement (9),
when cardiopulmonary collapse with pulmonary edema usual-
ly occurs. If appropriate cardiopulmonary supports are provid-
ed, patients may survive but usually have sequelae: for exam-
ple, central hypoventilation; cranial nerve palsy such as dys-
phagia, abducens palsy, and facial palsy; and shoulder weak-
ness and atrophy. These sequelae are compatible with magnet-
ic resonance imaging findings, which usually reveal high sig-
nal intensity from the pons to the cervical spinal cord (10). 
Did EV71 Circulate in Taiwan Before 1998?
Chang et al. initiated a seropidemiologic study before and
after the 1998 outbreak and found that in 1997 EV71 sero-
prevalence rates in adults and children >6 years of age were
57% to 67% (11). Lu et al. examined serial serum antibody
titers to EV71 in 81 children born in 1988 who had yearly
blood samples saved from 1989 to 1994 and in 1997 and 1999
(12). These researchers discovered that the incidence of EV71
seroconversion increased yearly from 3% to 11% between 1989
and 1997 and that 68% of these children had serologic evidence
of EV71 infections by 1997 (12). In addition, EV71 had been
isolated from patients with HFMD and poliomyelitis-like paral-
ysis in Taiwan as early as 1981 and 1986 (6,13). 
How Was the 1998 Outbreak Recognized?
The evidence presented above indicated that EV71 had cir-
culated in Taiwan for at least 16 years before 1998. However,
its clinical significance in Taiwan was not investigated before
1998. Severe cases of EV71 probably had occurred but had not
been recognized. In 1998, however, with the availability of spe-
cific EV71 monoclonal antibody, observant pediatricians in
Taiwan linked the association of EV71 with young children
dying of an unexplained acute illness. Both the physician-based
and hospital-based surveillance systems supplied critical infor-
mation leading to the recognition of the EV71 outbreaks and
provided the opportunity for the study of EV71 infections.
Why Did the 1998 Outbreak Occur?
The 1998 EV71 outbreak in Taiwan may have occurred for
the following reasons: l) mutation of the virus to a form with
increased virulence; 2) presence of host factors—the accumu-
lation of susceptible populations and individual genetic suscep-
tibility. The outreak was recognized because of the establish-
ment of a sentinel surveillance system (clinical and laboratory)
and the awareness of health care workers. 
Outbreaks after 1998
One year after the large outbreaks in 1998, cases of EV71
infection decreased dramatically with only one fatal EV71 case
in 1999. However, severe and fatal EV71 cases recurred, and
25 children died in 2000 and 26 in 2001 (Table). EV71 out-
breaks likely will continue to occur for the next several years in
Taiwan.
Virus Studies
Wang et al. showed that most EV71 strains isolated in the
1998 outbreaks belonged to genotype C (14). In 1999 and
2000, however, genotype B was the most common strain.
Recombination strains did not develop between the two geno-
types, and particular EV71 genotypes did not affect clinical
outcome (14). 
Shih et al. analyzed the complete sequence of two selected
EV71 strains (15), one from a fatal case and the other from an
uncomplicated HFMD case. They found the identity to be sim-
ilar (from 97% to 100%) both in amino acid and nucleotide
sequence throughout the whole genome. Although the genetic
identity of EV71 in the fatal case and the uncomplicated case
was highly similar, their clinical outcomes were contrary.
Currently available genetic techniques cannot detect the
EV71 genetic difference except the difference in genotype. As
with polioviruses (16), a minor yet critical genetic change may
have led to unusual neurovirulence and caused this outbreak.
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Figure. Pathogenesis of severe EV71 infections.
Table. Number of confirmed severe/fatal enterovirus infections and 
viral isolation results from patients with fatal cases, Taiwan, 
1998–2000
a 
Case/enterovirus serotype  1998  1999  2000  2001 
Severe cases  405  35  291  389 
Fatal cases  78  9  41  55 
Enterovirus 71  34  1  25  26 
Coxsackievirus B3  0  3  1  0 
Echovirus 4  0  0  0  3 
Other enteroviruses  3  4  12  7 
Negative  31  1  3  13 
Specimens not available  10  0  0  6 
aData provided by the Center for Disease Control, Ministry of Health, Taiwan 
(1998–2001). Host Factors
Chang et al. showed that preepidemic EV71 seropreva-
lence rates were inversely correlated with death and disease
(11). Among a cohort of 81 children, Lu et al. found that the
annual EV71 seroconversion rates (3% to 4 %) between 1994
and 1997 were significantly lower than the rates (7% to 11%)
before 1994 (12). The incidence of EV71 infection was likely
lower between 1994 and 1997, and the accumulation of suscep-
tible hosts over the threshold density of EV71 caused the 1998
outbreak.
Our preliminary data did not show a difference in tumor
necrosis factor-a promoter polymorphism between uncompli-
cated and serious HFMD cases (unpub. data). We still believe
that individual host genetic factors may affect clinical severity.
Surveillance System
Pediatricians with a high index of suspicion and timely
autopsy findings were the major factors that caused the out-
break to be recognized. Otherwise, this fulminant cardiopul-
monary collapse would have been regarded as unexplained
death. At present, no single factor can fully explain why a fair-
ly common enterovirus can cause outbreaks of severe disease
in selected countries of the world.
Relationship between EV71 and HFMD and the Implications
In addition to the Bulgarian, Hungarian, Malaysian, and
Taiwanese EV71 outbreaks, a study in Singapore also showed
that the age-specific EV71 seroprevalence rate remained steady
at approximately 50% among children >5 years old in
1996–1997 (17); EV71 also caused a polio-like syndrome after
poliovirus was eradicated in Brazil (18), and the EV71 seropos-
itive rate among 12- to 15-year-old Brazilian children was
69.2% (19). Given the lack of adequate viral diagnostic labora-
tories and the difficulty in isolating some strains of the virus,
reports of EV71 infection may represent only the tip of the ice-
berg. Therefore, outbreaks of EV71 infection could spread to
other parts of the world and cause substantial illness and death. 
In conclusion, EV71 infection may have a fulminant clini-
cal course, and particularly because approximately 90% of the
fatal cases were in children <5 years of age, effective control
measures must be implemented: new antiviral drugs should be
developed and mass active vaccination of children <5 years old
in disease-endemic areas should be considered.
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